Table of Contents

Select this article
- N K Janz,
- W H Herman,
- M P Becker,
- D Charron-Prochownik,
- V L Shayna,
- T G Lesnick,
- S J Jacober,
- J D Fachnie,
- D F Kruger,
- and J A Sanfield
Diabetes and pregnancy. Factors associated with seeking pre-conception care.
Diabetes Care February 1995 18:157-165; doi:10.2337/diacare.18.2.157
- Abstract
Select this article
- M F Greene,
- E N Allred,
- and A Leviton
Maternal metabolic control and risk of microcephaly among infants of diabetic mothers.
Diabetes Care February 1995 18:166-169; doi:10.2337/diacare.18.2.166
- Abstract
Select this article
- M Krokowski,
- S Caillat-Zucman,
- J Timsit,
- E Larger,
- M Pehuet-Figoni,
- J F Bach,
- and C Boitard
Anti-bovine serum albumin antibodies: genetic heterogeneity and clinical relevance in adult-onset IDDM.
Diabetes Care February 1995 18:170-173; doi:10.2337/diacare.18.2.170
- Abstract
Select this article
- E J Boyko,
- D L Leonetti,
- R W Bergstrom,
- L Newell-Morris,
- and W Y Fujimoto
Visceral adiposity, fasting plasma insulin, and blood pressure in Japanese-Americans.
Diabetes Care February 1995 18:174-181; doi:10.2337/diacare.18.2.174
- Abstract
Select this article
- R G Nelson,
- W C Knowler,
- D J Pettitt,
- R L Hanson,
- and P H Bennett
Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM.
Diabetes Care February 1995 18:182-187; doi:10.2337/diacare.18.2.182
- Abstract
Select this article
- N L Eibl,
- H P Kopp,
- H R Nowak,
- C J Schnack,
- P G Hopmeier,
- and G Schernthaner
Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy.
Diabetes Care February 1995 18:188-192; doi:10.2337/diacare.18.2.188
- Abstract
Select this article
- S M Haffner,
- P Karhapaa,
- D L Rainwater,
- L Mykkanen,
- G Aldrete, Jr,
- and M Laakso
Insulin sensitivity and Lp(a) concentrations in normoglycemic men.
Diabetes Care February 1995 18:193-199; doi:10.2337/diacare.18.2.193
- Abstract
Select this article
- G Paolisso,
- G Di Maro,
- A D'Amore,
- N Passariello,
- A Gambardella,
- M Varricchio,
- and F D'Onofrio
Low-dose iloprost infusion improves insulin action in aged healthy subjects and NIDDM patients.
Diabetes Care February 1995 18:200-205; doi:10.2337/diacare.18.2.200
- Abstract
Select this article
- A Orlandini,
- M R Pastore,
- A Fossati,
- S Clerici,
- A Sergi,
- A Balini,
- M A Parlangeli,
- C Maffei,
- A Secchi,
- and G Pozza
Effects of personality on metabolic control in IDDM patients.
Diabetes Care February 1995 18:206-209; doi:10.2337/diacare.18.2.206
- Abstract
Select this article
- U Roll,
- A Nuber,
- A Schröder,
- E Gerlach,
- H U Janka,
- and A G Ziegler
No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM.
Diabetes Care February 1995 18:210-215; doi:10.2337/diacare.18.2.210
- Abstract
Select this article
- M J McNeely,
- E J Boyko,
- J H Ahroni,
- V L Stensel,
- G E Reiber,
- D G Smith,
- and R F Pecoraro
The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks?
Diabetes Care February 1995 18:216-219; doi:10.2337/diacare.18.2.216
- Abstract
Select this article
- A Ferrara,
- E Barrett-Connor,
- D L Wingard,
- and S L Edelstein
Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status. The Rancho Bernardo Study, 1984-1987.
Diabetes Care February 1995 18:220-225; doi:10.2337/diacare.18.2.220
- Abstract
Select this article
- C Ferri,
- A Carlomagno,
- S Coassin,
- R Baldoncini,
- M R Cassone Faldetta,
- O Laurenti,
- G Properzi,
- A Santucci,
- and G De Mattia
Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men.
Diabetes Care February 1995 18:226-233; doi:10.2337/diacare.18.2.226
- Abstract
Select this article
- G F Watts,
- R M ap Gwilym,
- J Mazurkiewicz,
- and J Coltart
Independent correlation between plasma lipoprotein(a) and angiographic coronary artery disease in NIDDM.
Diabetes Care February 1995 18:234-236; doi:10.2337/diacare.18.2.234
- Abstract
Select this article
- T W Gardner,
- R Klein,
- S E Moss,
- F L Ferris, 3rd,
- and N A Remaley
Digoxin does not accelerate progression of diabetic retinopathy.
Diabetes Care February 1995 18:237-240; doi:10.2337/diacare.18.2.237
- Abstract
Select this article
- T Hiraga,
- T Kobayashi,
- M Okubo,
- K Nakanishi,
- T Sugimoto,
- Y Ohashi,
- and T Murase
Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes.
Diabetes Care February 1995 18:241-244; doi:10.2337/diacare.18.2.241
- Abstract
Select this article
- D B Allison,
- F Paultre,
- C Maggio,
- N Mezzitis,
- and F X Pi-Sunyer
The use of areas under curves in diabetes research.
Diabetes Care February 1995 18:245-250; doi:10.2337/diacare.18.2.245
- Abstract
- D M Nathan
Inferences and implications. Do results from the Diabetes Control and Complications Trial apply in NIDDM?
Diabetes Care February 1995 18:251-257
Select this article
- R Klein
Hyperglycemia and microvascular and macrovascular disease in diabetes.
Diabetes Care February 1995 18:258-268; doi:10.2337/diacare.18.2.258
- Abstract
- A Lernmark
Glutamic acid decarboxylase antibodies and diabetes complications. Assay reliability and validity.
Diabetes Care February 1995 18:269-271
- R A Hegele,
- P W Connelly,
- C Palmason,
- D J Jenkins,
- and T M Wolever
Differential response of plasma lipoprotein(a) and apolipoprotein B in NIDDM subjects treated with acarbose.
Diabetes Care February 1995 18:272-273
- M Walker,
- R W Taylor,
- M W Stewart,
- L A Bindoff,
- M J Jackson,
- G K Alberti,
- and D M Turnbull
Insulin sensitivity and mitochondrial gene mutation.
Diabetes Care February 1995 18:273-275
- G Jermendy
QT interval in diabetic patients with cardiac autonomic neuropathy.
Diabetes Care February 1995 18:275-276
- M Odawara,
- Y Asakura,
- K Tada,
- Y Tsurushima,
- and K Yamashita
Mitochondrial gene mutation as a cause of insulin resistance.
Diabetes Care February 1995 18:275
- P S Chattopadhyay,
- S K Gupta,
- R Chattopadhyay,
- P K Kundu,
- and R Chakraborti
Malnutrition-related diabetes mellitus (MRDM), not diabetes-related malnutrition. A report on genuine MRDM.
Diabetes Care February 1995 18:276-277
- P S Denker,
- D R Leonard,
- P E DiMarco,
- and P A Maleski
An easy sliding scale formula.
Diabetes Care February 1995 18:278
- A S Sacerdote
Adrenal androgens and NIDDM.
Diabetes Care February 1995 18:278-279

Diabetes and pregnancy. Factors associated with seeking pre-conception care.

Maternal metabolic control and risk of microcephaly among infants of diabetic mothers.

Anti-bovine serum albumin antibodies: genetic heterogeneity and clinical relevance in adult-onset IDDM.

Visceral adiposity, fasting plasma insulin, and blood pressure in Japanese-Americans.

Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM.

Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy.

Insulin sensitivity and Lp(a) concentrations in normoglycemic men.

Low-dose iloprost infusion improves insulin action in aged healthy subjects and NIDDM patients.

Effects of personality on metabolic control in IDDM patients.

No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM.

The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks?

Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status. The Rancho Bernardo Study, 1984-1987.

Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men.

Independent correlation between plasma lipoprotein(a) and angiographic coronary artery disease in NIDDM.

Digoxin does not accelerate progression of diabetic retinopathy.

Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes.

The use of areas under curves in diabetes research.

Inferences and implications. Do results from the Diabetes Control and Complications Trial apply in NIDDM?

Hyperglycemia and microvascular and macrovascular disease in diabetes.

Glutamic acid decarboxylase antibodies and diabetes complications. Assay reliability and validity.

Differential response of plasma lipoprotein(a) and apolipoprotein B in NIDDM subjects treated with acarbose.

Insulin sensitivity and mitochondrial gene mutation.

QT interval in diabetic patients with cardiac autonomic neuropathy.

Mitochondrial gene mutation as a cause of insulin resistance.

Malnutrition-related diabetes mellitus (MRDM), not diabetes-related malnutrition. A report on genuine MRDM.

An easy sliding scale formula.

Adrenal androgens and NIDDM.

This Issue

Current Issue

From the Cover